Your browser doesn't support javascript.
loading
Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.
Chen, Ying; You, Fengtao; Jiang, Licui; Li, Jialu; Zhu, Xuejun; Bao, Yangyi; Sun, Xiang; Tang, Xiaowen; Meng, Huimin; An, Gangli; Zhang, Bozhen; Yang, Lin.
Afiliação
  • Chen Y; The Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China.
  • You F; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China.
  • Jiang L; The Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China.
  • Li J; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China.
  • Zhu X; Suzhou Cancer Immunotherapy and Diagnosis Engineering Center, Suzhou, China.
  • Bao Y; Persongen BioTherapeutics Co., Ltd., Suzhou, Jiangsu, PR China.
  • Sun X; Suzhou Cancer Immunotherapy and Diagnosis Engineering Center, Suzhou, China.
  • Tang X; Persongen BioTherapeutics Co., Ltd., Suzhou, Jiangsu, PR China.
  • Meng H; The Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China.
  • An G; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China.
  • Zhang B; Division of Hematology, Department of Medicine, Jiangsu Provincial Traditional Chinese Medical Hospital, Nanjing, Jiangsu Province, PR China.
  • Yang L; Binhu Hospital, The First People's Hospital of Hefei Group, Hefei, Anhui, PR China.
Oncotarget ; 8(23): 37128-37139, 2017 Jun 06.
Article em En | MEDLINE | ID: mdl-28415754

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Células Matadoras Naturais / Receptores de IgG / Citotoxicidade Celular Dependente de Anticorpos Limite: Animals / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Células Matadoras Naturais / Receptores de IgG / Citotoxicidade Celular Dependente de Anticorpos Limite: Animals / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article